Jörgen Elgqvist receives Assar Gabrielsson Award for thesis on radiation therapy


Jörgen Elgqvist receives Assar Gabrielsson Award for thesis on radiation therapy

Today, April 29, 2009, Doctor of Medicine Jörgen Elgqvist was named the
recipient of the Assar Gabrielsson Award for his thesis within cancer research
at Gothenburg University. The award is SEK 50,000 with a possibility to receive
a research grant of SEK 100,000 during the autumn of 2009.

Jörgen Elgqvist is active in the Department of Oncology at the Sahlgrenska
Academy in Gothenburg. He receives the award for his thesis Astatine-211
Radioimmunotherapy of Ovarian Cancer - Therapeutic Efficacy, Myelotoxicity, and
Radiation Dosimetry in an Animal Model.

Most fatal cases of cancer are due to the primary tumor already giving rise to
widespread small tumors called micrometastases prior to diagnosis. In his thesis
work, Jörgen Elgqvist studied radioimmunotherapy directed at very small tumors
in ovarian cancer. Radioimmunotherapy is a new radiation treatment method in
which a tumor-targeting antibody is linked to a radioactive substance.

The thesis studies are unique primarily due to the Astatine 211 radionuclide
employed. Astatine 211 with its short radiation range and high energy level has
several benefits in the treatment of microscopic tumors. Jörgen Elgqvist's
studies have provided the foundation for the continued clinical studies now
being conducted.

Assar Gabrielsson was one of Volvo's founders. In accordance with his wishes, a
fund was established for clinical cancer research.

2009-04-29

For further information, please contact Professor Gösta Granström, Executive
Director of the Assar Gabrielsson Fund, tel: +46 31 342 1276 or +46 703 80 61
20.  

Visit http://www.thenewsmarket.com/volvogroup to access broadcast-standard video
from Volvo Group. You can preview and request video, and choose to receive as a
MPEG2 file or by Beta SP tape. Registration and video is free to the media.

AB Volvo (publ) may be required to disclose the information provided herein
pursuant to the Securities Markets Act. The information was submitted for
publication at 12.00 p.m. CET, 29 April, 2009.


The Volvo Group is one of the world's leading manufacturers of trucks, buses and
construction equipment, drive systems for marine and industrial applications,
aerospace components and services. The Group also provides complete solutions
for financing and service. The Volvo Group, which employs about 100,000 people,
has production facilities in 19 countries and sells their products in more than
180 markets. Annual sales of the Volvo Group amount to about SEK 300 billion.
The Volvo Group is a publicly-held company headquartered in Göteborg, Sweden.
Volvo shares are listed on OMX Nordic Exchange Stockholm. Please visit
www.volvogroup.com for more information or visit www.volvogroup.mobi if you are
using your mobile phone.

Attachments

04292138.pdf
GlobeNewswire